首页> 美国卫生研究院文献>Therapeutic Advances in Psychopharmacology >Conversations with clients about antidepressant withdrawal and discontinuation
【2h】

Conversations with clients about antidepressant withdrawal and discontinuation

机译:与客户就抗抑郁药停药和停药进行的对话

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The issue of antidepressant withdrawal has received increased scientific and public interest over the last several years. Clinical practice guidelines suggesting that withdrawal symptoms tend to be mild and likely to resolve without treatment in a few short weeks are no longer consistent with the evidence, and ignore the experiences of some service users. Indeed, the latest changes to the National Institute for Care and Health Excellence (NICE) depression guidelines recommend that mental health providers inform clients about the potential for severe and long-lasting withdrawal symptoms. Facing rising rates of long-term antidepressant use across the US and UK, the lack of evidence of a favorable risk–benefit ratio for long-term use, and increased public awareness of these issues, mental health providers may benefit from guidance concerning how to initiate discussions about the risks of antidepressant withdrawal.
机译:在过去的几年中,抗抑郁药退出的问题受到了越来越多的科学和公众的关注。临床实践指南表明,戒断症状趋于轻度,并且可能在短短几周内无需治疗即可缓解,这已不再与证据相符,并且会忽略某些服务使用者的经验。的确,美国国家护理与健康研究院(NICE)抑郁症指南的最新变化建议精神卫生服务提供者告知患者严重和长期戒断症状的可能性。面对美国和英国的长期抗抑郁药使用率不断上升,缺乏长期使用有利的风险收益比的证据以及公众对这些问题的意识增强,精神卫生服务提供者可能会从如何发起有关抗抑郁药停药风险的讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号